A SIX1/EYA2 small molecule inhibitor disrupts EMT and metastasis
This study identified a novel compound reverses SIX1-mediated EMT and metastasis in breast cancer Overall design: RNA-seq was used to identify transcriptional signature that is influenced by SIX1 overexpression, and subsequently reversed by compound treatment